Group One Trading’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.7K Sell
4,300
-74,200
-95% -$157K ﹤0.01% 6508
2025
Q4
$176K Sell
78,500
-20,800
-21% -$54.7K ﹤0.01% 4494
2025
Q3
$240K Buy
+99,300
New +$264K ﹤0.01% 4484
2025
Q2
Sell
-500
Closed -$438 8511
2025
Q1
$438 Sell
500
-2,600
-84% -$3.61K ﹤0.01% 7296
2024
Q4
$5.24K Hold
3,100
﹤0.01% 6395
2024
Q3
$5.95K Buy
+3,100
New +$7.04K ﹤0.01% 5810
2023
Q4
Sell
-300
Closed -$1.37K 8040
2023
Q3
$1.37K Buy
+300
New +$2.87K ﹤0.01% 7148

Other funds holding PROK

Group One Trading's PROK Position: Q1 2026 in Review

Group One Trading sold out of ProKidney (PROK) in Q1 2026, closing a stake of 28,021 shares — an estimated $59.4K sold.

Group One Trading first reported a position in PROK in Q2 2024 and held it in 4 quarters. The position peaked at $62.8K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Group One Trading reported no remaining ProKidney position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 28,021 ProKidney shares in Q1 2026, an estimated $59.4K.
  • Group One Trading first reported a position in ProKidney in Q2 2024 and held it in 4 quarters.
  • Group One Trading's ProKidney position peaked at $62.8K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.